Profile
Christopher Slapak worked as Vice President-Early Phase Development Oncology at Eli Lilly & Co. from 1996 to 2017.
He also worked as an Assistant Professor at Dana-Farber Cancer Institute, Inc. and as an Associate Professor-Clinical at The Indiana University School of Medicine.
In 2018, he became the Chief Medical Officer at Prelude Therapeutics, Inc. and in 2020, he became the Chief Medical Officer at Vor Biopharma, Inc. Dr. Slapak received his undergraduate degree from The Ohio State University and his doctorate degree from Pritzker School of Medicine.
Former positions of Christopher Slapak
Companies | Position | End |
---|---|---|
VOR BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 2022-05-05 |
PRELUDE THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | 2019-05-31 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 2017-11-30 |
The Indiana University School of Medicine | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Christopher Slapak
Pritzker School of Medicine | Doctorate Degree |
The Ohio State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
VOR BIOPHARMA INC. | Health Technology |
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private companies | 1 |
---|---|
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
- Stock Market
- Insiders
- Christopher Slapak